Status:
COMPLETED
Dexamethasone for Cardiac Surgery Trial
Lead Sponsor:
UMC Utrecht
Conditions:
Systemic Inflammatory Response Syndrome
Cardiac Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a multicenter, randomized, double-blind trial, comparing clinical outcomes after the administration of high-dose dexamethasone versus placebo in patients undergoing heart surgery with the use ...
Eligibility Criteria
Inclusion
- All types of cardiac surgery in which cardiopulmonary bypass is used
Exclusion
- Age under 18 years
- Life-expectancy \< 6 months
- Emergency operations
- Re-operations within the same admission
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
4500 Patients enrolled
Trial Details
Trial ID
NCT00293592
Start Date
May 1 2006
End Date
December 1 2012
Last Update
April 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMC Utrecht
Utrecht, Netherlands, 3584CX